Trial Search Results
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility of efficacy) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
Stanford is currently accepting patients for this trial.
Leigh R. Hochberg, MD, PhD.
Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Device: Placement of the BrainGate2 sensor(s) into the motor-related cortex
- Clinical diagnosis of spinal cord injury, brainstem stroke, muscular dystrophy,
amyotrophic lateral sclerosis or other motor neuron disorders
- Complete or incomplete tetraplegia (quadriplegia)
- Must live within a three-hour drive of the Study site
- (There are additional inclusion criteria)
- Visual impairment such that extended viewing of a computer monitor would be difficult
even with ordinary corrective lenses
- Chronic oral or intravenous steroids or immunosuppressive therapy
- Other serious disease or disorder that could seriously affect ability to participate
in the study
- (There are additional exclusion criteria)
Ages Eligible for Study
18 Years - 75 Years
Genders Eligible for Study